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ACR Appropriateness Criteria®
Chronic Chest Pain—High Probability
of Coronary Artery Disease
James P. Earls, MDa, Richard D. White, MDb, Pamela K. Woodard, MDc,
Suhny Abbara, MDd, Michael K. Atalay, MD, PhDe, J. Jeffrey Carr, MD, MSCEf,
Linda B. Haramati, MD, MSg, Robert C. Hendel, MDh,i, Vincent B. Ho, MD, MBAjⴱ,
Udo Hoffman, MDd, Arfa R. Khan, MDk, Leena Mammen, MDl,
Edward T. Martin, III, MDi,m, Anna Rozenshtein, MDn, Thomas Ryan, MDi,o,
Joseph Schoepf, MDp, Robert M. Steiner, MDq, Charles S. White, MDr

Imaging is valuable in determining the presence, extent, and severity of myocardial ischemia and the severity of
obstructive coronary lesions in patients with chronic chest pain in the setting of high probability of coronary
artery disease. Imaging is critical for defining patients best suited for medical therapy or intervention, and
findings can be used to predict long-term prognosis and the likely benefit from various therapeutic options.
Chest radiography, radionuclide single photon-emission CT, radionuclide ventriculography, and conventional
coronary angiography are the imaging modalities historically used in evaluating suspected chronic myocardial
ischemia. Stress echocardiography, PET, cardiac MRI, and multidetector cardiac CT have all been more
recently shown to be valuable in the evaluation of ischemic heart disease. Other imaging techniques may be
helpful in those patients who do not present with signs classic for angina pectoris or in those patients who do
not respond as expected to standard management. The ACR Appropriateness Criteria® are evidence-based
guidelines for specific clinical conditions that are reviewed every 2 years by a multidisciplinary expert panel. The
guideline development and review include an extensive analysis of current medical literature from peerreviewed journals and the application of a well-established consensus methodology (modified Delphi) to rate
the appropriateness of imaging and treatment procedures by the panel. In those instances in which evidence is
lacking or not definitive, expert opinion may be used to recommend imaging or treatment.
Key Words: Appropriateness Criteria, myocardial ischemia, coronary artery disease, cardiac magnetic resonance imaging, multidetector cardiac CT, radionuclide single photon-emission CT
J Am Coll Radiol 2011;8:679-686. Copyright © 2011 American College of Radiology
This article is a U.S. government work, and is not subject to copyright in the United States.

a

Fairfax Radiological Consultants, Fairfax, Virginia.
University of Florida College of Medicine–Jacksonville, Jacksonville, Florida.

b
c

Mallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, Missouri.

d

Massachusetts General Hospital, Boston, Massachusetts.

n

Columbia Presbyterian Medical Center, New York, New York.
The Ohio State University Heart and Vascular Center, Columbus, Ohio.
p
Medical University of South Carolina, Charleston, South Carolina.
q
Temple University Health System, Philadelphia, Pennsylvania.
r
University of Maryland Hospital, Baltimore, Maryland.
o

e

The Warren Alpert School of Medicine at Brown University, Providence,
Rhode Island.

f

Wake Forest University Health Sciences, Winston-Salem, North Carolina.

g

Albert Einstein College of Medicine, Montefiore Medical Center, Bronx,
New York.
h
i
j

Uniformed Services University of the Health Sciences, Bethesda, Maryland.

k
l

Univeristy of Miami Miller School of Medicine, Miami, Florida.

American College of Cardiology, Bethesda, Maryland.
Long Island Jewish Medical Center, New Hyde Park, New York.

Advanced Radiology Services, Grand Rapids, Michigan.

m

Oklahoma Heart Institute, Tulsa, Oklahoma.

© 2011 American College of Radiology
0091-2182/11/$36.00 ● DOI 10.1016/j.jacr.2011.06.022

The ACR seeks and encourages collaboration with other organizations on
the development of the ACR Appropriateness Criteria® through society representation on expert panels. Participation by representatives from collaborating societies on the expert panel does not necessarily imply society endorsement of the final document.
ⴱ
The opinions or assertions contained herein are the private views of the
author and are not to be construed as official or reflecting the views of the
Uniformed Services University of the Health Sciences or the US Department
of Defense.
Corresponding author and reprints: James P. Earls, MD, American College
of Radiology, Department of Quality and Safety, 1891 Preston White Drive,
Reston, VA 20191; e-mail: jpearls@yahoo.com.

679

680 Journal of the American College of Radiology/ Vol. 8 No. 10 October 2011

SUMMARY OF LITERATURE REVIEW

Chronic chest pain of suspected cardiac origin is usually
a consequence of myocardial ischemia, representing an
imbalance between myocardial oxygen demand and coronary blood flow. This is usually caused by fixed, hemodynamically significant coronary stenosis due to atherosclerotic plaque formation leading to reduced myocardial
perfusion, which can also be caused by coronary spasm,
microvascular disease, or a combination of both. In the
setting of high probability of coronary artery disease
(CAD), flow-limiting epicardial coronary artery narrowing is likely. However, chest pain of myocardial ischemic
origin can also occur in patients with relatively normal
coronary arterial caliber but with conditions resulting in
increased demand for oxygenation (eg, increased myocardial mass and workload due to systemic arterial hypertension or aortic stenosis). Although the syndrome of
exertional angina pectoris is nearly always diagnostic of
chronic CAD, nonischemic cardiac (eg, myocarditis,
pericarditis) and extracardiac (eg, esophageal reflux or
spasm) etiologies should also be considered in the setting
of nonexertional or atypical chest pain.
In patients with chronic chest pain in the setting of
high probability of CAD, imaging has major and diverse
roles. First, imaging is valuable in determining and documenting the presence, extent, and severity of myocardial ischemia, hibernation, and scarring, on one hand, or
the presence, site, and severity of obstructive coronary
lesions on the other. Second, imaging findings are important in determining the course of management of patients with suspected chronic myocardial ischemia as well
as for defining those patients best suited for medical
therapy, angioplasty or stenting, or surgery. Third, imaging is also necessary to evaluate ventricular function
and end-systolic volume, both of which are important in
predicting the long-term prognosis and likely benefit
from various therapeutic options. Imaging studies are
also required to demonstrate abnormalities (eg, congenital or acquired coronary anomalies, severe left ventricular hypertrophy) that can produce angina in the absence
of coronary obstructive disease due to atherosclerosis.
The imaging modalities historically used in evaluating
suspected chronic myocardial ischemia are (1) chest radiography, (2) stress and rest radionuclide single photonemission CT (SPECT) myocardial perfusion imaging
(MPI), (3) radionuclide ventriculography with and without stress, and (4) catheter-based selective coronary angiography with or without left ventriculography. Stress
echocardiography, PET, cardiac MRI, and multidetector
cardiac CT have all been more recently shown to be
valuable in the evaluation of ischemic heart disease (see
Variant 1). In those patients who do not present with
signs classic for angina pectoris, or in those patients who
do not respond as expected to standard management, the
exclusion of noncardiac causes of chronic chest pain re-

quires the use of additional studies (eg, esophagography,
upper gastrointestinal series, and biliary ultrasound).
Chest Radiography

Chest radiography is an inexpensive test that can rapidly
demonstrate many noncardiac causes of chronic chest
pain, including a variety of diseases of the mediastinum,
pleura, or lung. It may also provide qualitative indirect
information about left ventricular function as reflected in
cardiac size and pulmonary vascular patterns (eg, pulmonary venous hypertension) [1]. However, chest radiography can neither establish nor exclude chronic ischemic
heart disease. In addition, it (including fluoroscopy) is
insensitive for the detecting coronary arterial calcification
[2]. Chest radiography, therefore, is of limited value in
symptomatic patients with high risk for CAD.
Imaging of Myocardium
SPECT. Stress SPECT MPI demonstrates relative myocardial perfusion defects, indicating the presence of myocardial ischemia. For this reason, it is considered an important first-line study in the evaluation of patients with
chronic chest pain and high likelihood of CAD. By acquiring rest and stress perfusion scans, it is possible to
demonstrate reversibility (ischemia) or irreversibility (infarction) of a myocardial perfusion defect. The territory
of the perfusion defect identifies the likely culprit coronary artery and can distinguish between significant single-vessel and multivessel coronary arterial obstructions
[3-12]. The magnitude of the abnormality and the presence of high-risk findings also assist in clinical decision
making [13,14].
Presently, SPECT perfusion agents labeled with
99m
Tc, such as 99mTc-sestamibi or 99mTc-tetrofosmin,
are used most commonly because of improved image
resolution, higher count density, and more favorable dosimetry. The sensitivity and specificity of 99mTc SPECT
in detecting CAD are equal to and usually superior to
those of 201Tl [15]. With the use of electrocardiographic
gating, and with improved imaging protocols and image
quality, the diagnostic accuracy of stress SPECT MPI for
detecting angiographically significant CAD is high (sensitivity, 87%-89%; specificity, 73%-75%) [16]. More
important, normal stress SPECT MPI results in patients
with intermediate to high likelihood of CAD predicts a
very low rate of cardiac death or nonfatal myocardial
infarction (ⱕ1% per year) [17]. Furthermore, SPECT
MPI may be used for risk stratification in scenarios such
as follow-up after percutaneous coronary intervention
and coronary artery bypass grafting or evaluation before
noncardiac surgery. Limitations of stress SPECT MPI
are its relatively high cost and relatively high radiation
dose.
Recently, new software algorithms such as iterative
reconstruction, maximum a posteriori noise regularization, and resolution recovery, as well as new hardware
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Table 1. Chronic Chest Pain — High Probability of CAD

Rating

Comments

SPECT MPI rest and
stress

Radiologic Procedure

9

Arteriography coronary

8

82

8

Strongest evidence. Fundamental test for reversible and irreversible
ischemic disease. Can segregate out those who need next study
(ie, coronary artery angiography). Fused SPECT and CCTA can
accurately measure plaque burden and identify the hemodynamic
functional significance of coronary stenoses.
Consider if high probability of CAD intervention is contemplated,
and/or noninvasive studies are equivocal. In setting of high
probability, provides opportunity to intervene.
PET perfusion imaging has advantages over SPECT, including
higher spatial and temporal resolution. Routine performance of
both PET and SPECT not necessary. Fused PET and CCTA can
accurately measure plaque burden and identify the hemodynamic
functional significance of coronary stenoses.
Similar sensitivity to stress SPECT MPI but has advantage of no
radiation. Some limitations due to LV anatomy, acoustic window,
body habitus, and experience of the physician.
Very good accuracy and negative predictive value in low-risk to
intermediate-risk groups. However, may have false-negatives in
high-risk group, and negative studies may still require further
diagnostic testing. Coronary calcification often found in older
high-risk patients (especially males) can limit coronary luminal
assessment.
Accuracy equivalent or superior to stress SPECT MPI. Diagnoses
hemodynamically significant CAD in patients with intermediate to
high likelihood of having significant stenosis. Higher diagnostic
accuracy than stress echocardiography. See statement regarding
contrast in text under “Anticipated Exceptions.”
Versatile, used to evaluate anatomy, function, valvular disease,
cardiomyopathies, and myocardial viability. Subendocardial scar
with or without wall motion abnormalities supports diagnosis of
CAD. Used before revascularization to evaluate viability. See
statement regarding contrast in text under “Anticipated
Exceptions.”
Incomplete examination for high CAD risk, unless with stress, even
if other etiologies may be present. May evaluate aortic and
pericardial disease, valve and chamber abnormalities.
Usual initial imaging study in cardiac patients. Although used
frequently, chest radiography can neither establish nor exclude
chronic ischemic heart disease. Insensitive for detecting coronary
arterial calcification [1]. Limited value in patients with high risk for
CAD.
Little value for defining cause of chronic chest pain in a particular
patient. Cannot exclude significant disease even if negative; high
scores suggest significant chronic coronary atherosclerotic
plaque load but cannot identify the vessels implicated.
Excludes many noncardiac causes of chest pain. May diagnose
source of pain such as pulmonary embolism, dissection, unstable
LV aneurysms, etc.
Useful in some cases but too many nonassessable segments given
current technology. Less sensitive for disease beyond the
proximal main branches.
Rarely still performed, largely unavailable, with limited expertise.
Stress ventriculography can be combined with SPECT MPI.
Little value in this setting. Occasionally used when atypical chest
pain raises suspicion of biliary disease.
Although there is growing evidence in support of use of these low–
radiation dose CCTA techniques rather than traditional CCTA
techniques, evidence of their applicability to patients with chronic
chest pain and high probability of CAD is not yet adequate.

Rb PET heart stress

Ultrasound
echocardiography
transthoracic stress
CTA coronary arteries with
contrast

8

MRI heart with stress, with
or without contrast

7

MRI heart function and
morphology, with or
without contrast

5

Ultrasound
echocardiography
transthoracic resting
X-ray chest

4

CT coronary calcium

3

CT chest with contrast

3

MRA coronary arteries

3

Radionuclide
ventriculography
Ultrasound abdomen

2

CTA coronary arteries with
contrast with advanced
low-dose techniques

7

3

1
No
consensus

Relative
Radiation
Level

⌷

⌷

⌷

⌷

⌷

⌷

Note: Rating scale: 1, 2, and 3 ⫽ usually not appropriate; 4, 5, and 6 ⫽ may be appropriate; 7, 8, and 9 ⫽ usually appropriate. CAD ⫽ coronary artery
disease; CCTA ⫽ coronary CT angiography; CTA ⫽ CT angiography; LV ⫽ left ventricular; MRA ⫽ MR angiography.

682 Journal of the American College of Radiology/ Vol. 8 No. 10 October 2011

and detector materials, have become available, allowing
image acquisitions at significantly shorter acquisition
times (one-fifth to one-half) or alternatively at lower
doses compared with conventional algorithms [18,19].
Stress radionuclide ventriculography consists of measurement of the ejection fraction and assessment of regional wall motion at rest and during stress. This technique can be used to identify patients with “balanced”
3-vessel disease, which can be missed on perfusion studies, as well as for differentiating attenuation artifacts from
myocardial infarction [9]. Stress ejection fraction has also
been shown to be an independent predictor of the risk for
cardiac death [20,21]. However, radionuclide ventriculography is rarely used because it has largely been replaced by SPECT MPI; hence, the availability of and
expertise with this method are very limited. In patients
with typical angina (high pretest likelihood of disease),
stress SPECT MPI is useful for estimating the extent
(single-vessel vs multivessel disease) and severity of coronary stenosis, which has relevance for prognosis, choice
among therapeutic options, and advisability of performing coronary arteriography.
Rb or 13N ammonium for assessing perfusion, or F-2-fluoro-2-deoxy-D-glucose for evaluating metabolism, is now recognized as a useful method for the evaluation of ischemic
heart disease. PET perfusion imaging has several advantages over SPECT, including higher spatial and temporal
resolution, superior attenuation and scatter correction,
and the capability to perform quantitative measurements. In a meta-analysis of 8 studies with 791 patients
evaluated for CAD by PET perfusion imaging, overall
sensitivity and specificity were determined to be 93%
and 92%, respectively [22]. In the same article, 3 studies
comparing 201Tl SPECT with 82Rb or 13N ammonium
PET were analyzed, and the overall accuracy of PET was
91%, compared with 81% for 201Tl SPECT. Gated PET
also provides assessment of left ventricular function and
overall provides important diagnostic and prognostic
data [23].
Newer hybrid PET scanners use CT for attenuation
correction (PET/CT). After the completion of the PET
study, coronary CT angiography (CCTA) can be performed. By coupling the PET perfusion examination
findings to CCTA, PET/CT permits the fusion of anatomic coronary arterial and functional (perfusion) myocardial information and enhances diagnostic accuracy
[24]. The fused examinations can accurately measure the
atherosclerotic burden and identify the hemodynamic
functional significance of coronary stenoses [25,26]. The
results of the combined examinations can more accurately identify patients for revascularization [26]. In a
study of 110 consecutive patients with combined stress
82
Rb PET perfusion imaging and CCTA, nearly half of
significant angiographic stenoses (47%) occurred without evidence of ischemia, whereas 50% of PET studies
PET. Myocardial PET imaging using

82

18

with normal results were associated with some abnormality on CCTA [25].
Echocardiography. Stress 2-D echocardiography for

contractility assessment is increasingly used for patients
with suspected regional wall motion abnormalities secondary to regional ischemia, in part because of the ubiquity of 2-D echocardiography. When exercise is not feasible, pharmacologic stress echocardiography may be
performed. A recent meta-analysis of 44 studies indicated
that stress echocardiography has similar sensitivity to
stress SPECT MPI (85% and 87%, respectively), with
higher specificity (77% vs 64%) [27].
Administration of an echocardiographic contrast
agent (ie, microbubbles) improves endocardial visualization at rest and more so during stress, leading to a higher
confidence of interpretation and greater accuracy in evaluating CAD [28]. According to a recent meta-analysis of
435 patients, dipyridamole and dobutamine stress contractility echocardiography had similar accuracy, specificity, and sensitivity for detecting CAD [29]. This technique is limited by the fact that it sometimes yields
nondiagnostic results and that suboptimal definition of
some regions of the left ventricle can lead to subjective
interpretation.
Resting transthoracic echocardiography can be useful
if pericardial effusion or valvular or chamber abnormalities are suspected. Transesophageal echocardiography is
generally not indicated for evaluating chronic angina; the
expense of this study does not justify its use in this setting. However, it is sometimes used for assessing aortic
pathology (eg, dissection, aneurysm, penetrating ulcer)
in patients with chronic chest pain, although CT and
MRI are less invasive and simpler to perform.
MRI. The use of MRI for evaluating general cardiac
anatomy and function, and specific aspects of valvular
disease, cardiomyopathies, myocardial viability, continues to evolve.
MRI myocardial perfusion techniques can be used to
assess for significant CAD. The diagnostic accuracy of
stress perfusion MRI has been evaluated in many studies
and has been found to be equivalent, and in many cases
superior, to stress SPECT MPI [30-40]. A recent metaanalysis of 37 studies with 2,191 patients undergoing
both exercise and dobutamine stress MRI contractility
evaluation and dipyridamole and adenosine MRI perfusion assessment found that imaging of stress-induced
wall motion abnormalities had sensitivity of 83% and
specificity of 86%; perfusion imaging demonstrated sensitivity of 91% and specificity of 81% [41].
Clinically, stress perfusion MRI has been used to diagnose hemodynamically significant CAD in patients
with intermediate to high likelihood of having significant
stenosis. Commonly, the technique is used in patients
with poor acoustic windows that would be likely to limit
the utility of stress echocardiography [42], and it has
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been shown to have higher diagnostic accuracy than dobutamine stress echocardiography [42,43]. The addition
of delayed-enhancement MRI using a gadolinium agent
is superior to stress perfusion MRI alone for detecting
CAD [44]. In patients with poor echocardiographic examinations, dobutamine stress MRI can be used to forecast myocardial infarction or cardiac death [45].
However, MRI is not suitable for evaluating individual patients with chronic chest pain with high probability
of CAD in the setting of implanted electronic devices (eg,
permanent pacemakers, implantable cardioverter defibrillators). In addition, general reliance on MRI in assessing chronic chest pain is hindered by the limited availability of advanced facilities and experienced personnel.
Imaging of Coronary Arteries
CT. Multidetector CT as well as electron-beam CT can
detect the presence and severity of calcification, a sign of
coronary atherosclerosis [46-53]. The coronary calcium
score is most commonly used for risk stratification in
asymptomatic patients. The absence of coronary calcification is useful evidence against myocardial ischemia
[46]. In a large study of 10,377 subjects, it was shown
that coronary calcium score provides independent incremental information in addition to traditional risk factors
in the prediction of all-cause mortality [54]. On the other
hand, patients who present with chronic chest pain of
suspected cardiac origin are typically older, with a significant proportion aged ⬎ 60 years. Because coronary calcium is so prevalent in this population, a “positive” coronary calcium score, even in the upper quartiles, cannot
be used as strong evidence of myocardial ischemia.
There is also increasing use of CCTA, specifically contrast-enhanced electrocardiographically gated multidetector CT, to evaluate for CAD. Studies using 64-slice
CCTA have shown high sensitivity and high negative
predictive value (NPV) for treatable stenoses of the coronary arteries [55-57]. A recent meta-analysis to evaluate
the diagnostic accuracy of 64-slice CCTA compared with
conventional selective coronary angiography included 27
studies and 1,740 patients and found sensitivity, specificity, positive predictive value, and NPV of 86%, 96%,
83%, and 96.5%, respectively, by per segment analysis,
and 97.5%, 91%, 93%, and 96.5%, respectively, by per
patient analysis [58]. The 64-slice CCTA Assessment by
Coronary Computed Tomographic Angiography of Individuals Undergoing Invasive Coronary Angiography
trial found 95% sensitivity, 83% specificity, 64% positive predictive value, and 99% NPV [59].
The pretest probability of CAD affects the diagnostic
performance of CCTA. The NPV of CCTA is significantly lower in patients with a high prevalence of CAD,
and negative results on CCTA only reduce the estimated
posttest probability of having obstructive disease to approximately 17% [60,61]. Because of this high residual
posttest probability despite negative results on CCTA,

many symptomatic high-probability patients are likely to
still require invasive selective coronary angiography. Coronary CT angiography, therefore, may be of limited clinical value in the evaluation of the group with high estimated pretest probability. There is also continuing
concern about the high radiation exposure with CCTA,
which has led to new dose-limited protocols.
Recent advances in cardiac CT imaging technology
allow further reduction of the radiation dose from CCTA
[62]; available new dose-reducing techniques include
prospective triggering [63-65], adaptive statistical iterative reconstruction [66], and high-pitch spiral acquisition [67]. However, these newer low-dose techniques
may not be the appropriate choice in all patients because
of their dependency on a combination of factors, including heart rate, rhythm, and clinical indication. Thus,
although these techniques are promising in terms of reducing patient radiation dose, their overall accuracy and
utility compared with standard coronary CT angiographic techniques are not yet completely defined.
MR Angiography (MRA). Although MRA of the pulmo-

nary and systemic vessels has matured significantly in the
past few years, MRA of the coronary arteries is still problematic because of their small size and incessant motion
tied to the respiratory and cardiac cycles. At this time,
coronary MRA should be limited to sites with extensive
experience and appropriate capabilities to exclude disease
in the proximal coronary arteries. At present, only CCTA
can noninvasively visualize coronary arteries on a routine
basis; in direct comparison, coronary MRA had similar
sensitivity but significantly lower specificity and accuracy
compared with CCTA [68].
Selective Coronary Angiography

Catheter-based selective coronary angiography remains
the coronary imaging modality with the highest spatial
and temporal resolution. Thus, although only projection
images are obtained (as opposed to 3-D volumes on
CCTA), selective coronary angiography is considered the
gold standard for depicting the anatomy and the severity
of obstructive CAD and some other coronary arterial
abnormalities (eg, spasm) [69]. Moreover, it is needed to
guide transluminal interventions.
There remains agreement that selective coronary angiography is indicated in patients in whom angina is not
adequately managed by vigorous medical therapy and in
those in whom left main stenosis or severe multivessel
CAD is suggested by results of stress SPECT MPI or
stress echocardiography.
Left ventricular catheterization and left ventriculography are generally indicated, but not always necessary, to
define ventricular function in patients with angina. In
many patients, left ventricular function can be evaluated
better using noninvasive studies (eg, echocardiography,
MRI).
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Other diagnostic studies, such as hepatobiliary ultrasound, should be considered only after a cardiac etiology
has been accurately excluded, using the imaging modalities and clinical evaluation described above.

Table 2. Relative radiation level designations
Pediatric Effective
Adult Effective
Relative
Dose Estimate
Dose Estimate
Radiation
Range (mSv)
Range (mSv)
Level
⌷

SUMMARY
●

●

●

●

The approach defined here for evaluating patients with
chronic chest pain of probable cardiac origin is supported by a substantial body of literature.
Stress SPECT MPI, stress PET, and stress echocardiography are used as frontline modalities to establish
the diagnosis and assess the severity of myocardial ischemia.
On the basis of the results of stress SPECT MPI, stress
PET, or stress echocardiography or a patient’s clinical
response to medical therapy, the next procedure is
usually selective coronary angiography.
Given the underlying high prevalence of CAD in this
patient population, the substitution of newer examinations (eg, MRI, CCTA) is promising for diagnosis
but awaits the results of comparative studies and cost
analysis. Their value may be seen in therapeutic planning (eg, myocardial “viability” assessment using MRI
for evaluating myocardial perfusion, contraction, and
scarring).

ANTICIPATED EXCEPTIONS

Nephrogenic systemic fibrosis is a disorder with a scleroderma-like presentation and a spectrum of manifestations that can range from limited clinical sequelae to
fatality. It seems to be related to both underlying severe
renal dysfunction and the administration of gadoliniumbased contrast agents. It has occurred primarily in patients on dialysis, rarely in patients with very limited
glomerular filtration rates (ie, ⬍30 mL/min/1.73 m2),
and almost never in other patients. There is growing
literature regarding nephrogenic systemic fibrosis. Although some controversy and lack of clarity remain,
there is a consensus that it is advisable to avoid all gadolinium-based contrast agents in dialysis-dependent patients unless the possible benefits clearly outweigh the
risk and to limit the type and amount in patients with
estimated glomerular filtration rates ⬍ 30 mL/min/1.73
m2. For more information, please see the ACR’s Manual
on Contrast Media [70].
RELATIVE RADIATION LEVEL INFORMATION

Potential adverse health effects associated with radiation
exposure are an important factor to consider when selecting the appropriate imaging procedure. Because there is a
wide range of radiation exposures associated with different diagnostic procedures, an relative radiation level indication has been included for each imaging examination. The relative radiation levels are based on effective
dose, which is a radiation dose quantity that is used to

0
⬍0.1
0.1-1
1-10
10-30
30-100

0
⬍0.03
0.03-0.3
0.3-3
3-10
10-30

Note: Relative radiation level assignments for some of the examinations
cannot be made, because the actual patient doses in these procedures
vary as a function of a number of factors (eg, region of the body exposed
to ionizing radiation, the imaging guidance that is used). The relative
radiation levels for these examinations are designated as not specified.

estimate a population’s total radiation risk associated
with an imaging procedure. Patients in the pediatric age
group are at inherently higher risk from exposure, both
because of organ sensitivity and longer life expectancy
(relevant to the long latency that appears to accompany
radiation exposure). For these reasons, the relative radiation level dose estimate ranges for pediatric examinations
are compared with those specified for adults (Table 2).
Additional information regarding radiation dose assessment for imaging examinations can be found in ACR
Appropriateness Criteria®: Radiation Dose Assessment Introduction [71].
For additional information on ACR Appropriateness
Criteria®, refer to http://www.acr.org/ac.
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